Trial Profile
A double-blind, randomized, multicenter study to evaluate the effectiveness of the combination of valsartan and amlodipine in hypertensive patients not controlled on monotherapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Amlodipine/valsartan (Primary) ; Valsartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual patient number is 894 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (1 Jan 2007) added as reported by ClinicalTrials.gov.
- 22 Oct 2006 New trial record.